CRISPR-Cas-Based Diagnostics in Biomedicine: Principles, Applications, and Future Trajectories.

Biosensors (Basel) · 2025 · PMC12563714 · PMID 41149312

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

The rapid transition of CRISPR from a fundamental biological discovery to a versatile diagnostic platform underscores a significant trend in biotechnology: the swift translation of basic scientific understanding into applied technologies [ 7 , 16 ].

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.